Leo Pharma on leaving 22 markets: Freeing up resources enables us to invest in unmet drug needs

”We are dedicated to always putting the patient first,” states Leo Pharma’s CSR strategy, but how does add up to the firm’s exiting 22 of its 80 markets? According to EVP Becki Morison, it’s still all about the patient.

Photo: Leo Pharma / PR

Like most companies of a certain size, Leo Pharma has a corporate social responsibility strategy, CSR, purposed with throwing light on how the firm is integrating societal concerns into its practices and policies.

On Leo Pharma’s website, the firm’s CSR strategy proudly states: ”We are dedicated to always putting the patient first.”

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs